#AIEye #Podcast: GBT Technologies’ (OTC: $GTCH) CTO Discusses the Significance of #FDA Approval for the #qTerm Human Vital Signs Device; #Artificialintelligence
Point Roberts WA, Vancouver BC – January 27, 2021 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye, featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).
Listen
to today’s podcast:
https://www.investorideas.com/Audio/Podcasts/2021/012521-GTCH-qTerm.mp3
Read
this in full at https://www.investorideas.com/news/2021/artificial-intelligence/01271GTCH-qTerm.asp
GBT Technologies Inc. (OTC PINK:GTCH) recently announced that GBT Tokenize Corp, its joint venture, is now seeking approval for its qTerm human vital signs device with the United States Food and Drug Administration (FDA). In an interview with Investorideas.com, GBT’s CTO, Danny Rittman, explained that the rigour of the FDA approval process was necessary and beneficial to the product.
“We are expecting some improvements and
modifications because during the process of the FDA approval – and with their
own guidelines and standards – we may definitely need to do some,” he
said. “That’s something we’re looking forward to, because that’s only going to
make the device better, more accurate and more credentialed. The more
credentials we get for the device, the better for us. That’s the plan.”
FDA approval will also grant the qTerm
legitimacy in the eyes of consumers, Rittman explained in a recent press
release:
“Another
aspect is to gain potential customer's confidence and trust in the product's
performance and accuracy. We plan to offer the technology for personal,
hospital and clinical usage [in] seeking to comply with the industry's
standards and regulations.”
Rittman clarified however, that approval
from the FDA is not essential but rather that the company was pursuing it to
expand future market opportunities.
“FDA approval is not a must for qTerm, we
voluntarily do this certification in order to bring the device to a clinical
level which can open a whole world of possibilities marketing wise (clinics,
hospitals, etc…),” he said. “The device can be introduced to the market as is
in many other wearables that are not defined as a “medical device”, if for
ramification only.”
In its first release, the qTerm will boast
the abilities to measure body temperature, blood oxygen level and heart rate.
GBT Tokenize will subsequently add blood pressure to this and these functions
will be accompanied by a smartphone app and web application that will keep a
history for the user's records, providing a geographical proximity alert and
record statistical data about the user's vitals.
“In
addition the device measures ambient temperatures to notify the user about an
efficient measurement environment for accuracy purposes.” Rittman added.
While there are other mobile health
detection devices out there, the qTerm is distinguished by its being powered by
GBT’s AI technology. Rittman indicated in the press release:
“…we
believe that its main advantage upon similar products is its Artificial
Intelligence technology that offers advanced features like real-time health
statistics, analytics, and monitoring.”
“The AI will basically collect the data,
track it, keep a history and will alert personally, per person in case of
abnormalities,” he said. “Assuming a person takes, on a daily basis, their
blood pressure, oxygen level or heart rate … the AI engine will notice
differences … and the user is going to get notifications.”
From
the press release: “Early detection of potential health issues, based on vitals
can be crucial and a life saver. Applying for an FDA clearance is a long
process but we strongly believe it will bring our technology to the highest
standards to be used by hospitals and individuals.”
Sam Mowers,
Investorideas.com
Read and hear other editions of the AI Eye
For a list of artificial intelligence stocks
on Investorideas.com visit here
Investors can trade these stocks and other
ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.
About
GBT Technologies Inc.
GBT Technologies Inc. (OTC PINK: GTCH)
(“GBT”) (http://gbtti.com)
is a development-stage company which considers itself a native IoT creator,
developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled
mobile technology platforms. GBT has a
portfolio of Intellectual Property that, when commercialized, will include
smart microchips, mobile and security applications and protocols, and
supporting cloud software. GBT’s system
envisions the creation of a global mesh network. The core of the system will be its advanced
microchip technology that can be installed in any mobile or fixed device
worldwide. GBT envisions this system as a low-cost, secure, private mesh
network between any enabled devices, providing shared processing, advanced
mobile database management/sharing and enhanced mobile features as an
alternative to traditional carrier services.
About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source
publishing third party news, research and original financial content. Learn
about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI
and IoT, mining, sports biotech, water, renewable energy and more. Investor
Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast
and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
The Investorideas.com podcasts are also
available on iTunes, Spotify, Tunein,
Stitcher, Spreaker.com, iHeartRadio and Google Play Music.
Visit the Podcast page at Investorideas.com:
https://www.investorideas.com/Audio/
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third
party sourced news, articles and equity research as well as creates original
content, including video, interviews and articles. Original content created by
investorideas is protected by copyright laws other than syndication rights. Our
site does not make recommendations for purchases or sale of stocks, services or
products. Nothing on our sites should be construed as an offer or solicitation
to buy or sell products or securities. All investing involves risk and possible
losses. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. Contact management and IR of
each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about
publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Disclosure: GTCH is a paid for
featured AI stock on Investorideas.com
Global investors must adhere to
regulations of each country. Please read Investorideas.com privacy
policy: https://www.investorideas.com/About/Private_Policy.asp
The AI Eye- Watching stock news, deal tracker and
advancements in artificial intelligence is an original content brand of
Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get
more Technology stock investor ideas - news, articles, podcasts
and stock directories
No comments:
Post a Comment